Schedule 13G ownership disclosure

Boston Therapeutics, Inc.

Security class unavailable · CUSIP: 101150100

Event date: 2015-07-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-043213
Form type
SC 13G
Filer
NANOMIX Corp
CIK
CIK 1473579
Filed
Jul 20, 2015
Reporting period
Jul 20, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub